CYCN
Cyclerion Therapeutics IncPINK
Healthcare • Biotechnology
Updated 8 days ago
Coverage limited
$3.36-20.94%
Close Sep 8, 2026
- Market cap
- $14.13M
- 1 month
- -5.9%
- 3 months
- +11.6%
- 1 year
- +51.7%
- 52-week range
- $1.08$6.38
- Dividend
- No dividends on record
- Short interest
- 18.1K sharessettled Aug 31, 2026 · -65.5% since Aug 14, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $1.9M
- Net income
- -$6.71M
- Free cash flow
- -$4.45M
- Book value
- $5.09M
- Total debt
- —
- P/E
- —
- Price / sales
- 7.4×
- Price / book
- 2.8×
- FCF yield
- -31.5%
- Net margin
- -353.0%
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if CYCN is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
2 top institutions tracked
as of 2026-Q2 (filed 2026-09-02)
Insider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
21 filers reported a long position in CYCN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Kalehua Capital Management LLC | $5.6M | 1.7M | New |
| FMR LLC | $2.2M | 649.5K | +13,603.5% |
| BALYASNY ASSET MANAGEMENT L.P. | $1.1M | 317.5K | New |
| ADAR1 Capital Management, LLC | $1M | 298.8K | New |
| BRAIDWELL LP | $531.9K | 156.9K | New |
| CITADEL ADVISORS LLC | $202.7K | 59.8K | +227.4% |
| GEODE CAPITAL MANAGEMENT, LLC | $155.5K | 45.9K | -45.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | $104.8K | 30.9K | +91.6% |
| Rangeley Capital, LLC | $82.4K | 24.3K | New |
| HRT FINANCIAL LP | $74K | 22.1K | New |
Get the Full Analysis for CYCN
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.